Search Results - "Taja‐Chayeb, Lucía"
-
1
DNA methyltransferases 3a and 3b are differentially expressed in the early stages of a rat liver carcinogenesis model
Published in Oncology reports (01-11-2014)“…Carcinogenesis is driven by the accumulation of mutations and abnormal DNA methylation patterns, particularly the hypermethylation of tumor-suppressor genes…”
Get full text
Journal Article -
2
Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients
Published in International journal of cancer (10-05-2003)“…It is known that cell‐free DNA circulates in plasma/serum of patients with cancer and that part of this DNA circulates as nucleosomes that can be quantified by…”
Get full text
Journal Article -
3
Cancer progression mediated by horizontal gene transfer in an in vivo model
Published in PloS one (28-12-2012)“…It is known that cancer progresses by vertical gene transfer, but this paradigm ignores that DNA circulates in higher organisms and that it is biologically…”
Get full text
Journal Article -
4
Analysis of the CAG tract length in the Androgen Receptor gene in Mexican patients with nonsyndromic cryptorchidism
Published in Journal of pediatric endocrinology & metabolism : JPEM (27-07-2021)“…Cryptorchidism is the most common genitourinary birth defect in live newborn males and is considered as an important risk factor for testicular germ cell…”
Get more information
Journal Article -
5
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma
Published in Cellular and molecular neurobiology (01-08-2021)“…Astrocytoma is the most common type of primary brain tumor. The risk factors for astrocytoma are poorly understood; however, germline genetic variants account…”
Get full text
Journal Article -
6
Ether à go-go potassium channels as human cervical cancer markers
Published in Cancer research (Chicago, Ill.) (01-10-2004)“…Ether a go-go (EAG) potassium channels display oncogenic properties. In normal tissues, EAG mRNA is almost exclusively expressed in brain, but it is expressed…”
Get full text
Journal Article -
7
Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient
Published in Boletín médico del Hospital Infantil de México (Spanish edition) (01-07-2021)“…Background: Patients with familial erythrocytosis type 2 have no increased risk of von Hippel-Lindau-associated tumors, although mutations in the VHL gene…”
Get full text
Journal Article -
8
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
Published in BMC cancer (29-04-2005)“…The antihypertensive compound hydralazine is a known demethylating agent. This phase I study evaluated the tolerability and its effects upon DNA methylation…”
Get full text
Journal Article -
9
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Published in Expert opinion on investigational drugs (04-05-2018)“…Cancer cells have increased glycolysis and glutaminolysis. Their third feature is increased de novo lipogenesis. As such, fatty acid (FA) synthesis enzymes are…”
Get more information
Journal Article -
10
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
Published in Cancer cell international (31-01-2006)“…Among the epigenetic alterations occurring in cancer, DNA hypermethylation and histone hypoacetylation are the focus of intense research because their…”
Get full text
Journal Article -
11
NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review
Published in PloS one (06-04-2023)“…Arylamine N-acetyltransferase 2 has been related to drug side effects and cancer susceptibility; its protein structure and acetylation capacity results from…”
Get full text
Journal Article -
12
NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review
Published in PloS one (06-04-2023)“…Arylamine N-acetyltransferase 2 has been related to drug side effects and cancer susceptibility; its protein structure and acetylation capacity results from…”
Get full text
Journal Article -
13
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer
Published in Cancer cell international (02-10-2006)“…Despite significant achievements in the treatment of cervical cancer, it is still a deadly disease; hence newer therapeutical modalities are needed…”
Get full text
Journal Article -
14
Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
Published in BMC cancer (27-06-2005)“…It has been shown that free DNA circulates in serum plasma of patients with cancer and that at least part is present in the form of oligo- and monucleosomes, a…”
Get full text
Journal Article -
15
Growth inhibition and transcriptional effects of ribavirin in lymphoma
Published in Oncology reports (01-09-2019)“…Ribavirin exhibits inhibitory effects on the epigenetic enzyme enhancer of zeste homolog 2 (EZH2), which participates in lymphomagenesis. Additionally,…”
Get full text
Journal Article -
16
A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell Lymphoma
Published in Revista de investigacion clinica (05-11-2021)“…BACKGROUNDNovel prognostic factors in patients with diffuse large B-cell lymphoma (DLBCL) are required in the era of Rituximab. OBJECTIVEThe objective of the…”
Get full text
Journal Article -
17
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells
Published in PloS one (12-03-2012)“…Down regulation of genes coding for nucleoside transporters and drug metabolism responsible for uptake and metabolic activation of the nucleoside gemcitabine…”
Get full text
Journal Article -
18
Antitumor Effects of Systemic DNAse I and Proteases in an In Vivo Model
Published in Integrative cancer therapies (01-12-2016)“…Background. Cell-free DNA circulates in cancer patients and induces in vivo cell transformation and cancer progression in susceptible cells. Based on this, we…”
Get full text
Journal Article -
19
Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial
Published in Annals of hematology (01-04-2011)“…Decitabine and azacitidine, two DNA methyltransferase (DNMT) inhibitors, are the current standard of treatment for myelodysplastic syndrome (MDS). Histone…”
Get full text
Journal Article -
20
A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
Published in Oncology letters (01-12-2019)“…Lonidamine, 6-Diazo-5-oxo-L-norleucine (DON) and orlistat are well known inhibitors of glycolysis, glutaminolysis and of fatty acid synthesis, respectively…”
Get full text
Journal Article